Macrogenics, inc. (MGNX)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Operating activities
Cash flows from operating activities
Net loss

-151,811

-171,453

-19,626

-58,528

-20,140

-38,313

-261

8,362

6,717

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense

10,845

8,279

7,228

7,608

2,863

1,822

1,193

960

1,147

Stock-based compensation

19,571

16,520

14,744

12,165

7,847

3,244

862

838

2,347

Fair value adjustment of warrant liability

-

-

-

-

-

-

626

-151

-1,459

Changes in operating assets and liabilities:
Accounts receivable

-16,839

15,941

10,878

1,540

-1,711

931

-42

-1,352

-12,551

Prepaid expenses

4,878

3,255

-332

1,677

-2,405

3,239

834

91

-76

Restricted cash

-

-

-

-

-300

-105

0

-177

0

Other assets

1,578

4,580

-262

-276

285

1,179

375

-1

133

Accounts payable

787

1,554

-1,544

2,232

-163

-1,500

-570

-7,312

-10,271

Accrued expenses

-6,057

3,506

12,832

4,659

3,545

4,346

2,347

185

272

Lease liabilities

2,881

0

0

-

-

-

-

-

-

Lease exit liability

-

-

-

-

-3,293

-1,439

-629

-534

-447

Deferred revenue

-20,869

13,405

6,533

-4,191

-12,223

3,317

-16,676

-10,810

-4,275

Deferred rent

0

-971

6,115

-1,134

4,650

-234

103

441

232

Other liabilities

0

-298

-1,593

-3,549

-878

1,242

0

-

-

Net cash used in operating activities

-134,270

-153,234

14,405

-43,679

-13,661

-32,759

-14,172

-6,582

6,757

Cash flows from investing activities
Cash flows from investing activities
Purchases of marketable securities

264,399

132,750

135,122

347,762

142,910

0

0

-

-

Proceeds from sale and maturities of marketable securities

189,330

214,348

242,401

288,894

0

0

-

-

-

Purchases of property and equipment

4,289

24,954

29,403

11,381

9,197

3,572

2,961

940

500

Net cash provided by (used in) investing activities

-79,358

56,644

77,876

-70,249

-152,107

-3,572

-2,961

-940

-500

Cash flows from financing activities
Cash flows from financing activities
Proceeds from issuance of preferred stock

-

-

-

-

-

-

-

-

12,014

Proceeds from issuance of common stock, net of offering costs

118,657

103,259

34,244

0

203,467

76,716

84,771

-

70

Proceeds from stock option exercises and ESPP purchases

1,315

1,992

1,144

1,893

911

744

1,100

47

-

Purchase of treasury stock

0

260

40

39

29

19

0

-

-

Net cash provided by financing activities

119,972

104,991

35,348

1,854

204,349

77,441

85,871

47

12,085

Net change in cash and cash equivalents

-93,656

8,401

127,629

-112,074

38,581

41,110

68,738

-7,475

18,342

Supplemental Cash Flow Information [Abstract]
Right-of-use assets modified in exchange for operating lease obligations

6,408

0

0

-

-

-

-

-

-

Fair value of warrants received

0

6,130

0

0

-

-

-

-

-

Conversion of preferred stock

-

-

-

-

-

-

2,947

-

0